Table of Contents Author Guidelines Submit a Manuscript
Journal of Drug Delivery
Volume 2013, Article ID 869718, 22 pages
http://dx.doi.org/10.1155/2013/869718
Review Article

Targeting Antigens to Dendritic Cell Receptors for Vaccine Development

1VA Consulting Services, Melbourne, VIC, Australia
2College of Health and Biomedicine, Victoria University, VIC, Australia
3Institute of Pathophysiology and Allergy Research, Centre for Pathophysiology, Immunology and Infectiology, Medical University of Vienna, Vienna, Austria
4Department of Chemistry, University of Ioannina, Ioannina, Greece

Received 12 December 2012; Accepted 11 July 2013

Academic Editor: Ali Nokhodchi

Copyright © 2013 Vasso Apostolopoulos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. S. Wilson and J. A. Villadangos, “Regulation of antigen presentation and cross-presentation in the dendritic cell network: acts, hypothesis, and immunological implications,” Advances in Immunology, vol. 86, pp. 241–305, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. R. A. B. Ezekowitz, K. Sastry, P. Bailly, and A. Warner, “Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells,” Journal of Experimental Medicine, vol. 172, no. 6, pp. 1785–1794, 1990. View at Publisher · View at Google Scholar · View at Scopus
  3. S. E. Fanibunda, D. N. Modi, J. S. Gokral, and A. H. Bandivdekar, “HIV gp120 binds to mannose receptor on vaginal epithelial cells and induces production of matrix metalloproteinases,” PLoS ONE, vol. 6, no. 11, Article ID e28014, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Cardona-Maya, P. A. Velilla, C. J. Montoya, Á. Cadavid, and M. T. Rugeles, “In vitro human immunodeficiency virus and sperm cell interaction mediated by the mannose receptor,” Journal of Reproductive Immunology, vol. 92, no. 1-2, pp. 1–7, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Apostolopoulos and I. F. McKenzie, “Role of the mannose receptor in the immune response,” Current Molecular Medicine, vol. 1, no. 4, pp. 469–474, 2001. View at Google Scholar · View at Scopus
  6. V. Apostolopoulos, N. Barnes, G. A. Pietersz, and I. F. C. McKenzie, “Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses,” Vaccine, vol. 18, no. 27, pp. 3174–3184, 2000. View at Google Scholar · View at Scopus
  7. A. Avraméas, D. McIlroy, A. Hosmalin et al., “Expression of a mannose/fucose membrane lectin on human dendritic cells,” European Journal of Immunology, vol. 26, no. 2, pp. 394–400, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Apostolopoulos, G. A. Pietersz, S. Gordon, L. Martinez-Pomares, and I. F. McKenzie, “Aldehyde-mannan antigen complexes target the MHC class I antigen-presentation pathway,” European Journal of Immunology, vol. 30, pp. 1714–1723, 2000. View at Google Scholar
  9. A. J. Engering, M. Cella, D. Fluitsma et al., “The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells,” European Journal of Immunology, vol. 27, no. 9, pp. 2417–2425, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. M. C. A. A. Tan, A. M. Mommaas, J. W. Drijfhout et al., “Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells,” European Journal of Immunology, vol. 27, no. 9, pp. 2426–2435, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. K. C. Sheng, D. S. Pouniotis, M. D. Wright et al., “Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells,” Immunology, vol. 118, no. 3, pp. 372–383, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. V. Apostolopoulos, G. A. Pietersz, B. E. Loveland, M. S. Sandrin, and I. F. C. Mckenzie, “Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 22, pp. 10128–10132, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Apostolopoulos, G. A. Pietersz, and I. F. C. McKenzie, “Cell-mediated immune responses to MUC1 fusion protein coupled to mannan,” Vaccine, vol. 14, no. 9, pp. 930–938, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. C. J. Lees, V. Apostolopoulos, B. Acres, C. S. Ong, V. Popovski, and I. F. C. McKenzie, “The effect of T1 and T2 cytokines on the cytotoxic T cell response to mannan-MUC1,” Cancer Immunology Immunotherapy, vol. 48, no. 11, pp. 644–652, 2000. View at Google Scholar · View at Scopus
  15. C. J. Lees, V. Apostolopoulos, and I. F. C. McKenzie, “Cytokine production from murine CD4 and CD8 cells after mannan-MUC1 immunization,” Journal of Interferon and Cytokine Research, vol. 19, no. 12, pp. 1373–1379, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. S. A. Lofthouse, V. Apostolopoulos, G. A. Pietersz, W. Li, and I. F. C. McKenzie, “Induction of T1 (cytotoxic lymphocyte) and/or T2 (antibody) responses to a mucin-1 tumour antigen,” Vaccine, vol. 15, no. 14, pp. 1586–1593, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. I. F. C. McKenzie, V. Apostolopoulos, C. Lees et al., “Oxidised mannan antigen conjugates preferentially stimulate T1 type immune responses,” Veterinary Immunology and Immunopathology, vol. 63, no. 1-2, pp. 185–190, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. G. A. Pietersz, W. Li, V. Popovski, J. A. Caruana, V. Apostolopoulos, and I. F. C. McKenzie, “Parameters for using mannan-MUC1 fusion protein to induce cellular immunity,” Cancer Immunology Immunotherapy, vol. 45, no. 6, pp. 321–326, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Apostolopoulos, S. A. Lofthouse, V. Popovski, G. Chelvanayagam, M. S. Sandrin, and I. F. C. McKenzie, “Peptide mimics of a tumor antigen induce functional cytotoxic T cells,” Nature Biotechnology, vol. 16, no. 3, pp. 276–280, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Apostolopoulos, C. Osinski, and I. F. C. Mckenzie, “MUC1 cross-reactive Galα(1,3)Gal antibodies in humans switch immune responses from cellular to humoral,” Nature Medicine, vol. 4, no. 3, pp. 315–320, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. V. Apostolopoulos, D. S. Pouniotis, P. J. van Maanen et al., “Delivery of tumor associated antigens to antigen presenting cells using penetratin induces potent immune responses,” Vaccine, vol. 24, no. 16, pp. 3191–3202, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Karanikas, L. A. Hwang, J. Pearson et al., “Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein,” Journal of Clinical Investigation, vol. 100, no. 11, pp. 2783–2792, 1997. View at Google Scholar · View at Scopus
  23. V. Karanikas, J. Lodding, V. C. Maino, and I. F. C. McKenzie, “Flow cytometric measurement of intracellular cytokines detects immune responses in MUC1 immunotherapy,” Clinical Cancer Research, vol. 6, no. 3, pp. 829–837, 2000. View at Google Scholar · View at Scopus
  24. V. Karanikas, G. Thynne, P. Mitchell et al., “Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection,” Journal of Immunotherapy, vol. 24, no. 2, pp. 172–183, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. B. E. Loveland, A. Zhao, S. White et al., “Mannan-MUC1-pulsed dendritic cell immunotherapy: a phase I trial in patients with adenocarcinoma,” Clinical Cancer Research, vol. 12, no. 3, pp. 869–877, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Katsara, J. Matsoukas, G. Deraos, and V. Apostolopoulos, “Towards immunotherapeutic drugs and vaccines against multiple sclerosis,” Acta Biochimica et Biophysica Sinica, vol. 40, no. 7, pp. 636–642, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Katsara, G. Minigo, M. Plebanski, and V. Apostolopoulos, “The good, the bad and the ugly: how altered peptide ligands modulate immunity,” Expert Opinion on Biological Therapy, vol. 8, no. 12, pp. 1873–1884, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. T. V. Tselios, F. N. Lamari, I. Karathanasopoulou et al., “Synthesis and study of the electrophoretic behavior of mannan conjugates with cyclic peptide analogue of myelin basic protein using lysine-glycine linker,” Analytical Biochemistry, vol. 347, no. 1, pp. 121–128, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Katsara, E. Yuriev, P. A. Ramsland et al., “Mannosylation of mutated MBP83-99 peptides diverts immune responses from Th1 to Th2,” Molecular Immunology, vol. 45, no. 13, pp. 3661–3670, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Katsara, E. Yuriev, P. A. Ramsland et al., “Altered peptide ligands of myelin basic protein (MBP87-99) conjugated to reduced mannan modulate immune responses in mice,” Immunology, vol. 128, no. 4, pp. 521–533, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Katsara, G. Deraos, T. Tselios, J. Matsoukas, and V. Apostolopoulos, “Design of novel cyclic altered peptide ligands of myelin basic protein MBP83-99 that modulate immune responses in SJL/J mice,” Journal of Medicinal Chemistry, vol. 51, no. 13, pp. 3971–3978, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Katsara, G. Deraos, T. Tselios et al., “Design and synthesis of a cyclic double mutant peptide (cyclo(87-99)[A 91,A96]MBP87-99) induces altered responses in mice after conjugation to mannan: implications in the immunotherapy of multiple sclerosis,” Journal of Medicinal Chemistry, vol. 52, no. 1, pp. 214–218, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Katsara, E. Yuriev, P. A. Ramsland et al., “A double mutation of MBP83-99 peptide induces IL-4 responses and antagonizes IFN-γ responses,” Journal of Neuroimmunology, vol. 200, no. 1-2, pp. 77–89, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. C. K. Tang, K. C. Sheng, V. Apostolopoulos, and G. A. Pietersz, “Protein/peptide and DNA vaccine delivery by targeting C-type lectin receptors,” Expert Review of Vaccines, vol. 7, no. 7, pp. 1005–1018, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Hattori, S. Kawakami, Y. Lu, K. Nakamura, F. Yamashita, and M. Hashida, “Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration,” Journal of Gene Medicine, vol. 8, no. 7, pp. 824–834, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. C. K. Tang, J. Lodding, G. Minigo et al., “Mannan-mediated gene delivery for cancer immunotherapy,” Immunology, vol. 120, no. 3, pp. 325–335, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Minigo, A. Scholzen, C. K. Tang et al., “Poly-l-lysine-coated nanoparticles: a potent delivery system to enhance DNA vaccine efficacy,” Vaccine, vol. 25, no. 7, pp. 1316–1327, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. C. K. Tang, K. C. Sheng, D. Pouniotis et al., “Oxidized and reduced mannan mediated MUC1 DNA immunization induce effective anti-tumor responses,” Vaccine, vol. 26, no. 31, pp. 3827–3834, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Srinivas, P. P. Karmali, D. Pramanik et al., “Cationic amphiphile with shikimic acid headgroup shows more systemic promise than its mannosyl analogue as DNA vaccine carrier in dendritic cell based genetic immunization,” Journal of Medicinal Chemistry, vol. 53, no. 3, pp. 1387–1391, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. K. C. Sheng, M. Kalkanidis, D. S. Pouniotis, M. D. Wright, G. A. Pietersz, and V. Apostolopoulos, “The adjuvanticity of a mannosylated antigen reveals TLR4 functionality essential for subset specialization and functional maturation of mouse dendritic cells,” Journal of Immunology, vol. 181, no. 4, pp. 2455–2464, 2008. View at Google Scholar · View at Scopus
  41. K. C. Sheng, M. Kalkanidis, D. S. Pouniotis et al., “Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo,” European Journal of Immunology, vol. 38, no. 2, pp. 424–436, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Toda, N. Ishii, E. Okada et al., “HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-γ antibody,” Immunology, vol. 92, no. 1, pp. 111–117, 1997. View at Google Scholar · View at Scopus
  43. Z. Cui, C. H. Hsu, and R. J. Mumper, “Physical characterization and macrophage cell uptake of mannan-coated nanoparticles,” Drug Development and Industrial Pharmacy, vol. 29, no. 6, pp. 689–700, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. C. Foged, C. Arigita, A. Sundblad, W. Jiskoot, G. Storm, and S. Frokjaer, “Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition,” Vaccine, vol. 22, no. 15-16, pp. 1903–1913, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. J. S. Thomann, B. Heurtault, S. Weidner et al., “Antitumor activity of liposomal ErbB2/HER2 epitope peptide-based vaccine constructs incorporating TLR agonists and mannose receptor targeting,” Biomaterials, vol. 32, no. 20, pp. 4574–4583, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Espuelas, C. Thumann, B. Heurtault, F. Schuber, and B. Frisch, “Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes,” Bioconjugate Chemistry, vol. 19, no. 12, pp. 2385–2393, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Hamdy, A. Haddadi, A. Shayeganpour, J. Samuel, and A. Lavasanifar, “Activation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticles,” Pharmaceutical Research, vol. 28, no. 9, pp. 2288–2301, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. H. Shiku, L. Wang, Y. Ikuta et al., “Development of a cancer vaccine: peptides, proteins, and DNA,” Cancer Chemotherapy and Pharmacology, vol. 46, pp. S77–S82, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. H. L. Jiang, M. L. Kang, J. S. Quan et al., “The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization,” Biomaterials, vol. 29, no. 12, pp. 1931–1939, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. U. Wattendorf, G. Coullerez, J. Vörös, M. Textor, and H. P. Merkle, “Mannose-based molecular patterns on stealth microspheres for receptor-specific targeting of human antigen-presenting cells,” Langmuir, vol. 24, no. 20, pp. 11790–11802, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. P. M. Moyle, C. Olive, M. F. Ho et al., “Toward the development of prophylactic and therapeutic human papillomavirus type-16 lipopeptide vaccines,” Journal of Medicinal Chemistry, vol. 50, no. 19, pp. 4721–4727, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. P. Presicce, A. Taddeo, A. Conti, M. L. Villa, and S. Della Bella, “Keyhole limpet hemocyanin induces the activation and maturation of human dendritic cells through the involvement of mannose receptor,” Molecular Immunology, vol. 45, no. 4, pp. 1136–1145, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. S. A. Porcelli, “The CD1 family: a third lineage of antigen-presenting molecules,” Advances in Immunology, vol. 59, pp. 1–98, 1995. View at Google Scholar · View at Scopus
  54. S. A. Porcelli and R. L. Modlin, “CD1 and the expanding universe of T cell antigens,” Journal of Immunology, vol. 155, no. 8, pp. 3709–3710, 1995. View at Google Scholar · View at Scopus
  55. T. I. Prigozy, P. A. Sieling, D. Clemens et al., “The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules,” Immunity, vol. 6, no. 2, pp. 187–197, 1997. View at Publisher · View at Google Scholar · View at Scopus
  56. V. Ramakrishna, J. F. Treml, L. Vitale et al., “Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules,” Journal of Immunology, vol. 172, no. 5, pp. 2845–2852, 2004. View at Google Scholar · View at Scopus
  57. L. Z. He, V. Ramakrishna, J. E. Connolly et al., “A novel human cancer vaccine elicits cellular responses to the tumor-associated antigen, human chorionic gonadotropin β,” Clinical Cancer Research, vol. 10, no. 6, pp. 1920–1927, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. V. Ramakrishna, J. P. Vasilakos, J. D. Tario Jr., M. A. Berger, P. K. Wallace, and T. Keler, “Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells,” Journal of Translational Medicine, vol. 5, article 5, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. M. A. Morse, D. A. Bradley, T. Keler et al., “CDX-1307: a novel vaccine under study as treatment for muscle-invasive bladder cancer,” Expert Review of Vaccines, vol. 10, no. 6, pp. 733–742, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. M. A. Morse, R. Chapman, J. Powderly et al., “Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with toll-like receptor stimulation to induce immunity to self-antigens in cancer patients,” Clinical Cancer Research, vol. 17, no. 14, pp. 4844–4853, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. T. Tsuji, J. Matsuzaki, M. P. Kelly et al., “Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity,” Journal of Immunology, vol. 186, no. 2, pp. 1218–1227, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. J. S. Lam, M. K. Mansour, C. A. Specht, and S. M. Levitz, “A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity,” Journal of Immunology, vol. 175, no. 11, pp. 7496–7503, 2005. View at Google Scholar · View at Scopus
  63. J. S. Lam, H. Huang, and S. M. Levitz, “Effect of differential N-linked and O-linked mannosylation on recognition of fungal antigens by dendritic cells,” PLoS ONE, vol. 2, no. 10, Article ID e1009, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. G. Ahlen, L. Strindelius, T. Johansson et al., “Mannosylated mucin-type immunoglobulin fusion proteins enhance antigen-specific antibody and T lymphocyte responses,” PloS One, vol. 7, no. 10, Article ID e46959, 2012. View at Publisher · View at Google Scholar
  65. D. J. Betting, X. Y. Mu, K. Kafi et al., “Enhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect cells involves mannose receptor targeting to antigen presenting cells,” Vaccine, vol. 27, no. 2, pp. 250–259, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. M. K. Mansour, L. S. Schlesinger, and S. M. Levitz, “Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors,” Journal of Immunology, vol. 168, no. 6, pp. 2872–2879, 2002. View at Google Scholar · View at Scopus
  67. D. Pietrella, C. Corbucci, S. Perito, G. Bistoni, and A. Vecchiarelli, “Mannoproteins from Cryptococcus neoformans promote dendritic cell maturation and activation,” Infection and Immunity, vol. 73, no. 2, pp. 820–827, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. B. J. Appelmelk, I. van Die, S. J. van Vliet, C. M. J. E. Vandenbroucke-Grauls, T. B. H. Geijtenbeek, and Y. van Kooyk, “Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells,” Journal of Immunology, vol. 170, no. 4, pp. 1635–1639, 2003. View at Google Scholar · View at Scopus
  69. S. G. Turville, J. Arthos, K. MacDonald et al., “HIV gp120 receptors on human dendritic cells,” Blood, vol. 98, no. 8, pp. 2482–2488, 2001. View at Publisher · View at Google Scholar · View at Scopus
  70. T. B. H. Geijtenbeek, D. S. Kwon, R. Torensma et al., “DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells,” Cell, vol. 100, no. 5, pp. 587–597, 2000. View at Google Scholar · View at Scopus
  71. T. B. H. Geijtenbeek, R. Torensma, S. J. van Vliet et al., “Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses,” Cell, vol. 100, no. 5, pp. 575–585, 2000. View at Google Scholar · View at Scopus
  72. C. P. Alvarez, F. Lasala, J. Carrillo, O. Muñiz, A. L. Corbí, and R. Delgado, “C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola Virus in cis and in trans,” Journal of Virology, vol. 76, no. 13, pp. 6841–6844, 2002. View at Publisher · View at Google Scholar · View at Scopus
  73. A. A. Bashirova, T. B. H. Geijtenbeek, G. C. F. van Duijnhoven et al., “A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection,” Journal of Experimental Medicine, vol. 193, no. 6, pp. 671–678, 2001. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Cambi, K. Gijzen, I. J. M. de Vries et al., “The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells,” European Journal of Immunology, vol. 33, no. 2, pp. 532–538, 2003. View at Publisher · View at Google Scholar · View at Scopus
  75. P. Y. Lozach, H. Lortat-Jacob, A. de Lacroix de Lavalette et al., “DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2,” Journal of Biological Chemistry, vol. 278, no. 22, pp. 20358–20366, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. B. Tassaneetrithep, T. H. Burgess, A. Granelli-Piperno et al., “DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells,” Journal of Experimental Medicine, vol. 197, no. 7, pp. 823–829, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. S. J. van Vliet, L. Steeghs, S. C. M. Bruijns et al., “Variation of Neisseria gonorrhoeae lipooligosaccharide directs dendritic cell-induced T helper responses,” PLoS Pathogens, vol. 5, no. 10, Article ID e1000625, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. M. Emara, P. J. Royer, J. Mahdavi, F. Shakib, and A. M. Ghaemmaghami, “Retagging identifies dendritic cell-specific intercellular adhesion molecule-3 (ICAM3)-grabbing non-integrin (DC-SIGN) protein as a novel receptor for a major allergen from house dust mite,” Journal of Biological Chemistry, vol. 287, no. 8, pp. 5756–5763, 2012. View at Publisher · View at Google Scholar · View at Scopus
  79. T. B. H. Geijtenbeek, D. J. E. B. Krooshoop, D. A. Bleijs et al., “DC-SIGN-1CAM-2 interaction mediates dendritic cell trafficking,” Nature Immunology, vol. 1, no. 4, pp. 353–357, 2000. View at Google Scholar · View at Scopus
  80. A. Engering, T. B. H. Geijtenbeek, S. J. van Vliet et al., “The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells,” Journal of Immunology, vol. 168, no. 5, pp. 2118–2126, 2002. View at Google Scholar · View at Scopus
  81. K. W. Schjetne, K. M. Thompson, T. Aarvak, B. Fleckenstein, L. M. Sollid, and B. Bogen, “A mouse Cκ-specific T cell clone indicates that DC-SIGN is an efficient target for antibody-mediated delivery of T cell epitopes for MHC class II presentation,” International Immunology, vol. 14, no. 12, pp. 1423–1430, 2002. View at Publisher · View at Google Scholar · View at Scopus
  82. P. J. Tacken, I. J. M. de Vries, K. Gijzen et al., “Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody,” Blood, vol. 106, no. 4, pp. 1278–1285, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. A. Kretz-Rommel, F. Qin, N. Dakappagari et al., “In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models,” Journal of Immunotherapy, vol. 30, no. 7, pp. 715–726, 2007. View at Publisher · View at Google Scholar · View at Scopus
  84. P. J. Tacken, W. Ginter, L. Berod et al., “Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation,” Blood, vol. 118, no. 15, pp. 4111–4119, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. Y. Akiyama, K. Maruyama, N. Nara et al., “Antitumor effects induced by dendritic cell-based immunotherapy against established pancreatic cancer in hamsters,” Cancer Letters, vol. 184, no. 1, pp. 37–47, 2002. View at Publisher · View at Google Scholar · View at Scopus
  86. R. K. Gieseler, G. Marquitan, M. J. Hahn et al., “DC-SIGN-specific liposomal targeting and selective intracellular compound delivery to human myeloid dendritic cells: implications for HIV disease,” Scandinavian Journal of Immunology, vol. 59, no. 5, pp. 415–424, 2004. View at Publisher · View at Google Scholar · View at Scopus
  87. L. J. Cruz, P. J. Tacken, R. Fokkink et al., “Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro,” Journal of Controlled Release, vol. 144, no. 2, pp. 118–126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. O. Srinivas, P. Larrieu, E. Duverger et al., “Synthesis of glycocluster—tumor antigenic peptide conjugates for dendritic cell targeting,” Bioconjugate Chemistry, vol. 18, no. 5, pp. 1547–1554, 2007. View at Publisher · View at Google Scholar · View at Scopus
  89. C. A. Aarnoudse, M. Bax, M. Sánchez-Hernández, J. J. García-Vallejo, and Y. van Kooyk, “Glycan modification of the tumor antigen gp100 targets DC-SIGN to enhance dendritic cell induced antigen presentation to T cells,” International Journal of Cancer, vol. 122, no. 4, pp. 839–846, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. J. Wang, Y. Zhang, J. Wei et al., “Lewis X oligosaccharides targeting to DC-SIGN enhanced antigen-specific immune response,” Immunology, vol. 121, no. 2, pp. 174–182, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. S. K. Singh, J. Stephani, M. Schaefer et al., “Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation,” Molecular Immunology, vol. 47, no. 2-3, pp. 164–174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. H. Chen, B. Yuan, Z. Zheng, Z. Liu, and S. Wang, “Lewis X oligosaccharides-heparanase complex targeting to DCs enhance antitumor response in mice,” Cellular Immunology, vol. 269, no. 2, pp. 144–148, 2011. View at Publisher · View at Google Scholar · View at Scopus
  93. W. W. J. Unger, A. J. van Beelen, S. C. Bruijns et al., “Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells,” Journal of Controlled Release, vol. 160, no. 1, pp. 88–95, 2012. View at Publisher · View at Google Scholar · View at Scopus
  94. J. J. Garcia-Vallejo, M. Ambrosini, A. Overbeek et al., “Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells,” Molecular Immunology, vol. 53, pp. 387–397, 2012. View at Google Scholar
  95. L. Yang, H. Yang, K. Rideout et al., “Engineered lentivector targeting of dendritic cells for in vivo immunization,” Nature Biotechnology, vol. 26, no. 3, pp. 326–334, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. A. Tai, S. Froelich, K. I. Joo, and P. Wang, “Production of lentiviral vectors with enhanced efficiency to target dendritic cells by attenuating mannosidase activity of mammalian cells,” Journal of Biological Engineering, vol. 5, article 1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  97. L. J. Cruz, P. J. Tacken, J. M. Pots, R. Torensma, S. I. Buschow, and C. G. Figdor, “Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN,” Biomaterials, vol. 33, no. 16, pp. 4229–4239, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. D. A. Mitchell, A. J. Fadden, and K. Drickamer, “A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands,” Journal of Biological Chemistry, vol. 276, no. 31, pp. 28939–28945, 2001. View at Publisher · View at Google Scholar · View at Scopus
  99. N. Dakappagari, T. Maruyama, M. Renshaw et al., “Internalizing antibodies to the C-type lectins, L-SIGN and DC-SIGN, inhibit viral glycoprotein binding and deliver antigen to human dendritic cells for the induction of T cell responses,” Journal of Immunology, vol. 176, no. 1, pp. 426–440, 2006. View at Google Scholar · View at Scopus
  100. C. G. Park, K. Takahara, E. Umemoto et al., “Five mouse homologues of the human dendritic cell C-type lectin, DC-SIGN,” International Immunology, vol. 13, no. 10, pp. 1283–1290, 2001. View at Google Scholar · View at Scopus
  101. C. Galustian, C. G. Park, W. Chai et al., “High and low affinity carbohydrate ligands revealed for murine SIGN-R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN-R3 and langerin,” International Immunology, vol. 16, no. 6, pp. 853–866, 2004. View at Publisher · View at Google Scholar · View at Scopus
  102. E. A. Koppel, I. S. Ludwig, B. J. Appelmelk, Y. van Kooyk, and T. B. H. Geijtenbeek, “Carbohydrate specificities of the murine DC-SIGN homologue mSIGNR1,” Immunobiology, vol. 210, no. 2–4, pp. 195–201, 2005. View at Publisher · View at Google Scholar · View at Scopus
  103. Y. S. Kang, J. Y. Kim, S. A. Bruening et al., “The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 1, pp. 215–220, 2004. View at Publisher · View at Google Scholar · View at Scopus
  104. Y. S. Kang, S. Yamazaki, T. Iyoda et al., “SIGN-R1, a novel C-type lectin expressed by marginal zone macrophages in spleen, mediates uptake of the polysaccharide dextran,” International Immunology, vol. 15, no. 2, pp. 177–186, 2003. View at Publisher · View at Google Scholar · View at Scopus
  105. P. R. Taylor, G. D. Brown, J. Herre, D. L. Williams, J. A. Willment, and S. Gordon, “The role of SIGNR1 and the β-glucan receptor (Dectin-1) in the nonopsonic recognition of yeast by specific macrophages,” Journal of Immunology, vol. 172, no. 2, pp. 1157–1162, 2004. View at Google Scholar · View at Scopus
  106. Y. Zhou, H. Kawasaki, S. C. Hsu et al., “Oral tolerance to food-induced systemic anaphylaxis mediated by the C-type lectin SIGNR1,” Nature Medicine, vol. 16, no. 10, pp. 1128–1133, 2010. View at Publisher · View at Google Scholar · View at Scopus
  107. W. Liu, L. Tang, G. Zhang et al., “Characterization of a novel C-type lectin-like gene, LSECtin: demonstration of carbohydrate binding and expression in sinusoidal endothelial cells of liver and lymph node,” Journal of Biological Chemistry, vol. 279, no. 18, pp. 18748–18758, 2004. View at Publisher · View at Google Scholar · View at Scopus
  108. T. Gramberg, H. Hofmann, P. Möller et al., “LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus,” Virology, vol. 340, no. 2, pp. 224–236, 2005. View at Publisher · View at Google Scholar · View at Scopus
  109. Y. Li, B. Hao, X. Kuai et al., “C-type lectin LSECtin interacts with DC-SIGNR and is involved in hepatitis C virus binding,” Molecular and Cellular Biochemistry, vol. 327, no. 1-2, pp. 183–190, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. L. Tang, J. Yang, X. Tang, W. Ying, X. Qian, and F. He, “The DC-SIGN family member LSECtin is a novel ligand of CD44 on activated T cells,” European Journal of Immunology, vol. 40, no. 4, pp. 1185–1191, 2010. View at Publisher · View at Google Scholar · View at Scopus
  111. A. Dominguez-Soto, L. Aragoneses-Fenoll, E. Martin-Gayo et al., “The DC-SIGN-related lectin LSECtin mediates antigen capture and pathogen binding by human myeloid cells,” Blood, vol. 109, no. 12, pp. 5337–5345, 2007. View at Publisher · View at Google Scholar · View at Scopus
  112. Á. Domínguez-Soto, L. Aragoneses-Fenoll, F. Gómez-Aguado et al., “The pathogen receptor liver and lymph node sinusoidal endotelial cell C-type lectin is expressed in human Kupffer cells and regulated by PU.1,” Hepatology, vol. 49, no. 1, pp. 287–296, 2009. View at Publisher · View at Google Scholar · View at Scopus
  113. I. Caminschi, A. J. Corbett, C. Zahra et al., “Functional comparison of mouse CIRE/mouse DC-SIGN and human DC-SIGN,” International Immunology, vol. 18, no. 5, pp. 741–753, 2006. View at Publisher · View at Google Scholar · View at Scopus
  114. I. Caminschi, K. M. Lucas, M. A. O'Keeffe et al., “Molecular cloning of a C-type lectin superfamily protein differentially expressed by CD8α-splenic dendritic cells,” Molecular Immunology, vol. 38, no. 5, pp. 365–373, 2001. View at Publisher · View at Google Scholar · View at Scopus
  115. T. Gramberg, I. Caminschi, A. Wegele, H. Hofmann, and S. Pöhlmann, “Evidence that multiple defects in murine DC-SIGN inhibit a functional interaction with pathogens,” Virology, vol. 345, no. 2, pp. 482–491, 2006. View at Publisher · View at Google Scholar · View at Scopus
  116. B. Carrillo-Conde, E. H. Song, A. Chavez-Santoscoy et al., “Mannose-functionalized “pathogen-like” polyanhydride nanoparticles target C-type lectin receptors on dendritic cells,” Molecular Pharmaceutics, vol. 8, no. 5, pp. 1877–1886, 2011. View at Publisher · View at Google Scholar · View at Scopus
  117. A. V. Chavez-Santoscoy, R. Roychoudhury, N. L. B. Pohl, M. J. Wannemuehler, B. Narasimhan, and A. E. Ramer-Tait, “Tailoring the immune response by targeting C-type lectin receptors on alveolar macrophages using “pathogen-like” amphiphilic polyanhydride nanoparticles,” Biomaterials, vol. 33, no. 18, pp. 4762–4772, 2012. View at Publisher · View at Google Scholar · View at Scopus
  118. M. P. Torres, J. H. Wilson-Welder, S. K. Lopac et al., “Polyanhydride microparticles enhance dendritic cell antigen presentation and activation,” Acta Biomaterialia, vol. 7, no. 7, pp. 2857–2864, 2011. View at Publisher · View at Google Scholar · View at Scopus
  119. K. Takahara, Y. Yashima, Y. Omatsu et al., “Functional comparison of the mouse DC-SIGN, SIGNR1, SIGNR3 and Langerin, C-type lectins,” International Immunology, vol. 16, no. 6, pp. 819–829, 2004. View at Publisher · View at Google Scholar · View at Scopus
  120. L. F. Poulin, S. Henri, B. de Bovis, E. Devilard, A. Kissenpfennig, and B. Malissen, “The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells,” Journal of Experimental Medicine, vol. 204, no. 13, pp. 3119–3131, 2007. View at Publisher · View at Google Scholar · View at Scopus
  121. V. Flacher, F. Sparber, C. H. Tripp, N. Romani, and P. Stoitzner, “Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy,” Cancer Immunology, Immunotherapy, vol. 58, no. 7, pp. 1137–1147, 2009. View at Publisher · View at Google Scholar · View at Scopus
  122. V. Flacher, C. H. Tripp, P. Stoitzner et al., “Epidermal langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermis,” Journal of Investigative Dermatology, vol. 130, no. 3, pp. 755–762, 2010. View at Publisher · View at Google Scholar · View at Scopus
  123. J. Idoyaga, A. Lubkin, C. Fiorese et al., “Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 6, pp. 2384–2389, 2011. View at Publisher · View at Google Scholar · View at Scopus
  124. V. Flacher, C. H. Tripp, B. Haid et al., “Skin langerin+ dendritic cells transport intradermally injected anti-DEC-205 antibodies but are not essential for subsequent cytotoxic CD8+ T cell responses,” Journal of Immunology, vol. 188, no. 5, pp. 2146–2155, 2012. View at Publisher · View at Google Scholar · View at Scopus
  125. A. L. Flamar, S. Zurawski, F. Scholz et al., “Noncovalent assembly of anti-dendritic cell antibodies and antigens for evoking immune responses in vitro and in vivo,” Journal of Immunology, vol. 189, pp. 2645–2655, 2012. View at Google Scholar
  126. S. de Koker, B. G. de Geest, S. K. Singh et al., “Polyelectrolyte microcapsules as antigen delivery vehicles to dendritic cells: uptake, processing, and cross-presentation of encapsulated antigens,” Angewandte Chemie, vol. 48, no. 45, pp. 8485–8489, 2009. View at Publisher · View at Google Scholar · View at Scopus
  127. A. Takada, K. Fujioka, M. Tsuiji et al., “Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry,” Journal of Virology, vol. 78, no. 6, pp. 2943–2947, 2004. View at Publisher · View at Google Scholar · View at Scopus
  128. N. Suzuki, K. Yamamoto, S. Toyoshima, T. Osawa, and T. Irimura, “Molecular cloning and expression of cDNA encoding human macrophage C-type lectin: its unique carbohydrate binding specificity for Tn antigen,” Journal of Immunology, vol. 156, no. 1, pp. 128–135, 1996. View at Google Scholar · View at Scopus
  129. K. Yamamoto, C. Ishida, Y. Shinohara et al., “Interaction of immobilized recombinant mouse C-type macrophage lectin with glycopeptides and oligosaccharides,” Biochemistry, vol. 33, no. 26, pp. 8159–8166, 1994. View at Publisher · View at Google Scholar · View at Scopus
  130. C. Napoletano, A. Rughetti, M. P. Agervig Tarp et al., “Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells,” Cancer Research, vol. 67, no. 17, pp. 8358–8367, 2007. View at Publisher · View at Google Scholar · View at Scopus
  131. C. Napoletano, I. G. Zizzari, A. Rughetti et al., “Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation,” European Journal of Immunology, vol. 42, no. 4, pp. 936–945, 2012. View at Publisher · View at Google Scholar · View at Scopus
  132. T. Freire, X. Zhang, E. Dériaud et al., “Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvant,” Blood, vol. 116, no. 18, pp. 3526–3536, 2010. View at Publisher · View at Google Scholar · View at Scopus
  133. S. V. Kushchayev, T. Sankar, L. L. Eggink et al., “Monocyte galactose/N-acetylgalactosamine-specific C-type lectin receptor stimulant immunotherapy of an experimental glioma. Part 1: stimulatory effects on blood monocytes and monocyte-derived cells of the brain,” Cancer Management and Research, vol. 4, pp. 309–323, 2012. View at Publisher · View at Google Scholar
  134. K. Ariizumi, G. L. Shen, S. Shikano et al., “Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning,” Journal of Biological Chemistry, vol. 275, no. 26, pp. 20157–20167, 2000. View at Publisher · View at Google Scholar · View at Scopus
  135. G. D. Brown, “Dectin-1: a signalling non-TLR pattern-recognition receptor,” Nature Reviews Immunology, vol. 6, no. 1, pp. 33–43, 2006. View at Publisher · View at Google Scholar · View at Scopus
  136. P. R. Taylor, G. D. Brown, D. M. Reid et al., “The β-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages,” Journal of Immunology, vol. 169, no. 7, pp. 3876–3882, 2002. View at Google Scholar · View at Scopus
  137. E. P. McGreal, M. Rosas, G. D. Brown et al., “The carbohydrate-recognition domain of Dectin-2 is a C-type lectin with specificity for high mannose,” Glycobiology, vol. 16, no. 5, pp. 422–430, 2006. View at Publisher · View at Google Scholar · View at Scopus
  138. E. J. Ryan, A. J. Marshall, D. Magaletti et al., “Dendritic cell-associated lectin-1: a novel dendritic cell-associated, C-type lectin-like molecule enhances T cell secretion of IL-4,” Journal of Immunology, vol. 169, no. 10, pp. 5638–5648, 2002. View at Google Scholar · View at Scopus
  139. G. D. Brown, P. R. Taylor, D. M. Reid et al., “Dectin-1 is a major β-glucan receptor on macrophages,” Journal of Experimental Medicine, vol. 196, no. 3, pp. 407–412, 2002. View at Publisher · View at Google Scholar · View at Scopus
  140. P. R. Taylor, S. V. Tsoni, J. A. Willment et al., “Dectin-1 is required for β-glucan recognition and control of fungal infection,” Nature Immunology, vol. 8, no. 1, pp. 31–38, 2007. View at Publisher · View at Google Scholar · View at Scopus
  141. A. G. Rothfuchs, A. Bafica, C. G. Feng et al., “Dectin-1 interaction with Mycobacterium tuberculosis leads to enhanced IL-12p40 production by splenic dendritic cells,” Journal of Immunology, vol. 179, no. 6, pp. 3463–3471, 2007. View at Google Scholar · View at Scopus
  142. R. W. Carter, C. Thompson, D. M. Reid, S. Y. C. Wong, and D. F. Tough, “Induction of CD8+ T cell responses through targeting of antigen to Dectin-2,” Cellular Immunology, vol. 239, no. 2, pp. 87–91, 2006. View at Publisher · View at Google Scholar · View at Scopus
  143. R. W. Carter, C. Thompson, D. M. Reid, S. Y. C. Wong, and D. F. Tough, “Preferential induction of CD4+ T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1,” Journal of Immunology, vol. 177, no. 4, pp. 2276–2284, 2006. View at Google Scholar · View at Scopus
  144. H. Huang, G. R. Ostroff, C. K. Lee, C. A. Specht, and S. M. Levitz, “Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded β-Glucan particles,” mBio, vol. 1, no. 3, 2010. View at Publisher · View at Google Scholar · View at Scopus
  145. C. Huysamen, J. A. Willment, K. M. Dennehy, and G. D. Brown, “CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes,” Journal of Biological Chemistry, vol. 283, no. 24, pp. 16693–16701, 2008. View at Publisher · View at Google Scholar · View at Scopus
  146. D. Sancho, D. Mourão-Sá, O. P. Joffre et al., “Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin,” Journal of Clinical Investigation, vol. 118, no. 6, pp. 2098–2110, 2008. View at Publisher · View at Google Scholar · View at Scopus
  147. O. P. Joffre, D. Sancho, S. Zelenay, A. M. Keller, and C. Reis E Sousa, “Efficient and versatile manipulation of the peripheral CD4+ T-cell compartment by antigen targeting to DNGR-1/CLEC9A,” European Journal of Immunology, vol. 40, no. 5, pp. 1255–1265, 2010. View at Publisher · View at Google Scholar · View at Scopus
  148. S. Iborra, H. M. Izquierdo, M. Martínez-López, N. Blanco-Menéndez, C. Reis E Sousa, and D. Sancho, “The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice,” Journal of Clinical Investigation, vol. 122, no. 5, pp. 1628–1643, 2012. View at Publisher · View at Google Scholar · View at Scopus
  149. S. Zelenay, A. M. Keller, P. G. Whitney et al., “The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice,” Journal of Clinical Investigation, vol. 122, no. 5, pp. 1615–1627, 2012. View at Publisher · View at Google Scholar · View at Scopus
  150. I. Caminschi, A. I. Proietto, F. Ahmet et al., “The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement,” Blood, vol. 112, no. 8, pp. 3264–3273, 2008. View at Publisher · View at Google Scholar · View at Scopus
  151. M. H. Lahoud, F. Ahmet, S. Kitsoulis et al., “Targeting antigen to mouse dendritic cells via Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype,” Journal of Immunology, vol. 187, no. 2, pp. 842–850, 2011. View at Publisher · View at Google Scholar · View at Scopus
  152. A. S. J. Marshall, J. A. Willmen, H. H. Lin, D. L. Williams, S. Gordon, and G. D. Brown, “Identification and characterization of a novel human myeloid inhibitory C-type lectin-like receptor (MICL) that is predominantly expressed on granulocytes and monocytes,” Journal of Biological Chemistry, vol. 279, no. 15, pp. 14792–14802, 2004. View at Publisher · View at Google Scholar · View at Scopus
  153. A. B. H. Bakker, S. van den Oudenrijn, A. Q. Bakker et al., “C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia,” Cancer Research, vol. 64, no. 22, pp. 8443–8450, 2004. View at Publisher · View at Google Scholar · View at Scopus
  154. C. H. Chen, H. Floyd, N. E. Olson et al., “Dendritic-cell-associated C-type lectin 2 (DCAL-2) alters dendritic-cell maturation and cytokine production,” Blood, vol. 107, no. 4, pp. 1459–1467, 2006. View at Publisher · View at Google Scholar · View at Scopus
  155. Y. Han, M. Zhang, N. Li et al., “KLRL1, a novel killer cell lectinlike receptor, inhibits natural killer cell cytotoxicity,” Blood, vol. 104, no. 9, pp. 2858–2866, 2004. View at Publisher · View at Google Scholar · View at Scopus
  156. E. Pyz, C. Huysamen, A. S. J. Marshall, S. Gordon, P. R. Taylor, and G. D. Brown, “Characterisation of murine MICL (CLEC12A) and evidence for an endogenous ligand,” European Journal of Immunology, vol. 38, no. 4, pp. 1157–1163, 2008. View at Publisher · View at Google Scholar · View at Scopus
  157. M. Colonna, J. Samaridis, and L. Angman, “Molecular characterization of two novel C-type lectin-like receptors, one of which is selectively expressed in human dendritic cells,” European Journal of Immunology, vol. 30, no. 2, pp. 697–704, 2000. View at Google Scholar
  158. K. Suzuki-Inoue, Y. Kato, O. Inoue et al., “Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells,” Journal of Biological Chemistry, vol. 282, no. 36, pp. 25993–26001, 2007. View at Publisher · View at Google Scholar · View at Scopus
  159. C. Chaipan, E. J. Soilleux, P. Simpson et al., “DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets,” Journal of Virology, vol. 80, no. 18, pp. 8951–8960, 2006. View at Publisher · View at Google Scholar · View at Scopus
  160. K. Suzuki-Inoue, G. L. J. Fuller, Á. García et al., “Anovel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2,” Blood, vol. 107, no. 2, pp. 542–549, 2006. View at Publisher · View at Google Scholar · View at Scopus
  161. S. C. Hoffmann, C. Schellack, S. Textor et al., “Identification of CLEC12B, an inhibitory receptor on myeloid cells,” Journal of Biological Chemistry, vol. 282, no. 31, pp. 22370–22375, 2007. View at Publisher · View at Google Scholar · View at Scopus
  162. Y. Sobanov, A. Bernreiter, S. Derdak et al., “A novel cluster of lectin-like receptor genes expressed in monocytic, dendritic and endothelial cells maps close to the NK receptor genes in the human NK gene complex,” European Journal of Immunology, vol. 31, pp. 3493–3503, 2001. View at Google Scholar
  163. T. Sawamura, N. Kume, T. Aoyama et al., “An endothelial receptor for oxidized low-density lipoprotein,” Nature, vol. 386, no. 6620, pp. 73–77, 1997. View at Publisher · View at Google Scholar · View at Scopus
  164. S. Dunn, R. S. Vohra, J. E. Murphy, S. Homer-Vanniasinkam, J. H. Walker, and S. Ponnambalam, “The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease,” Biochemical Journal, vol. 409, no. 2, pp. 349–355, 2008. View at Publisher · View at Google Scholar · View at Scopus
  165. J. L. Mehta, J. Chen, P. L. Hermonat, F. Romeo, and G. Novelli, “Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders,” Cardiovascular Research, vol. 69, no. 1, pp. 36–45, 2006. View at Publisher · View at Google Scholar · View at Scopus
  166. Y. Delneste, G. Magistrelli, J. F. Gauchat et al., “Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation,” Immunity, vol. 17, no. 3, pp. 353–362, 2002. View at Publisher · View at Google Scholar · View at Scopus
  167. F. Meyer-Wentrup, D. Benitez-Ribas, P. J. Tacken et al., “Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-{alpha} production,” Blood, vol. 111, no. 8, pp. 4245–4253, 2008. View at Publisher · View at Google Scholar · View at Scopus
  168. F. Meyer-Wentrup, A. Cambi, B. J. Joosten et al., “DCIR is endocytosed into human dendritic cells and inhibits TLR8-mediated cytokine production,” Journal of Leukocyte Biology, vol. 85, no. 3, pp. 518–525, 2009. View at Publisher · View at Google Scholar · View at Scopus
  169. E. Klechevsky, A. L. Flamar, Y. Cao et al., “Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR,” Blood, vol. 116, no. 10, pp. 1685–1697, 2010. View at Publisher · View at Google Scholar · View at Scopus
  170. K. Ariizumi, G. L. Shen, S. Shikano et al., “Cloning of a second dendritic cell-associated C-type lectin (dectin-2) and its alternatively spliced isoforms,” Journal of Biological Chemistry, vol. 275, no. 16, pp. 11957–11963, 2000. View at Publisher · View at Google Scholar · View at Scopus
  171. L. Lopes, M. Dewannieux, U. Gileadi et al., “Immunization with a lentivector that targets tumor antigen expression to dendritic cells induces potent CD8+ and CD4+ T-cell responses,” Journal of Virology, vol. 82, no. 1, pp. 86–95, 2008. View at Publisher · View at Google Scholar · View at Scopus
  172. A. Dzionek, Y. Sohma, J. Nagafune et al., “BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon α/β induction,” Journal of Experimental Medicine, vol. 194, no. 12, pp. 1823–1834, 2001. View at Publisher · View at Google Scholar · View at Scopus
  173. W. Jian, W. J. Swiggard, C. Heufler et al., “The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing,” Nature, vol. 375, no. 6527, pp. 151–155, 1995. View at Google Scholar · View at Scopus
  174. M. Butler, A. S. Morel, W. J. Jordan et al., “Altered expression and endocytic function of CD205 in human dendritic cells, and detection of a CD205-DCL-1 fusion protein upon dendritic cell maturation,” Immunology, vol. 120, no. 3, pp. 362–371, 2007. View at Publisher · View at Google Scholar · View at Scopus
  175. K. Mahnke, M. Guo, S. Lee et al., “The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments,” Journal of Cell Biology, vol. 151, no. 3, pp. 673–683, 2000. View at Publisher · View at Google Scholar · View at Scopus
  176. L. Bonifaz, D. Bonnyay, K. Mahnke, M. Rivera, M. C. Nussenzweig, and R. M. Steinman, “Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance,” Journal of Experimental Medicine, vol. 196, no. 12, pp. 1627–1638, 2002. View at Publisher · View at Google Scholar · View at Scopus
  177. K. Mahnke, Y. Qian, S. Fondel, J. Brueck, C. Becker, and A. H. Enk, “Targeting of antigens to activated dendritic cells in vivo cures metastatic melanoma in mice,” Cancer Research, vol. 65, no. 15, pp. 7007–7012, 2005. View at Publisher · View at Google Scholar · View at Scopus
  178. A. Charalambous, M. Oks, G. Nchinda, S. Yamazaki, and R. M. Steinman, “Dendritic cell targeting of survivin protein in a xenogeneic form elicits strong CD4+ T cell immunity to mouse survivin,” Journal of Immunology, vol. 177, no. 12, pp. 8410–8421, 2006. View at Google Scholar · View at Scopus
  179. B. Wang, N. Zaidi, L. Z. He et al., “Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice,” Breast Cancer Research, vol. 14, no. 2, article R39, 2012. View at Publisher · View at Google Scholar · View at Scopus
  180. L. Bozzacco, C. Trumpfheller, F. P. Siegal et al., “DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 4, pp. 1289–1294, 2007. View at Publisher · View at Google Scholar · View at Scopus
  181. G. Nchinda, J. Kuroiwa, M. Oks et al., “The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells,” Journal of Clinical Investigation, vol. 118, no. 4, pp. 1427–1436, 2008. View at Publisher · View at Google Scholar · View at Scopus
  182. C. Cheong, J. H. Choi, L. Vitale et al., “Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti-human DEC205 monoclonal antibody,” Blood, vol. 116, no. 19, pp. 3828–3838, 2010. View at Publisher · View at Google Scholar · View at Scopus
  183. M. Tenbusch, G. Nchinda, M. Storcksdieck genannt Bonsmann, V. Temchura, and K. Überla, “Targeting the antigen encoded by adenoviral vectors to the DEC205 receptor modulates the cellular and humoral immune response,” International Immunology, vol. 25, no. 4, pp. 247–258, 2013. View at Publisher · View at Google Scholar
  184. C. Grossmann, M. Tenbusch, G. Nchinda et al., “Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands,” BMC Immunology, vol. 10, article 43, 2009. View at Publisher · View at Google Scholar · View at Scopus
  185. J. Maamary, F. Array, Q. Gao et al., “Newcastle disease virus expressing a dendritic cell-targeted HIV Gag protein induces a potent Gag-specific immune response in mice,” Journal of Virology, vol. 85, no. 5, pp. 2235–2246, 2011. View at Publisher · View at Google Scholar · View at Scopus
  186. C. Demangel, J. Zhou, A. B. H. Choo, G. Shoebridge, G. M. Halliday, and W. J. Britton, “Single chain antibody fragments for the selective targeting of antigens to dendritic cells,” Molecular Immunology, vol. 42, no. 8, pp. 979–985, 2005. View at Publisher · View at Google Scholar · View at Scopus
  187. J. N. H. Stern, D. B. Keskin, Z. Kato et al., “Promoting tolerance to proteolipid protein-induced experimental autoimmune encephalomyelitis through targeting dendritic cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 40, pp. 17280–17285, 2010. View at Publisher · View at Google Scholar · View at Scopus
  188. P. Brož, S. M. Benito, C. Saw et al., “Cell targeting by a generic receptor-targeted polymer nanocontainer platform,” Journal of Controlled Release, vol. 102, no. 2, pp. 475–488, 2005. View at Publisher · View at Google Scholar · View at Scopus
  189. P. Bansal, P. Mukherjee, S. K. Basu, A. George, V. Bal, and S. Rath, “MHC class I-restricted presentation of maleylated protein binding to scavenger receptors,” Journal of Immunology, vol. 162, no. 8, pp. 4430–4437, 1999. View at Google Scholar · View at Scopus
  190. R. Abraham, N. Singh, A. Mukhopadhyay, S. K. Basu, V. Bal, and S. Rath, “Modulation of immunogenicity and antigenicity of proteins by maleylation to target scavenger receptors on macrophages,” Journal of Immunology, vol. 154, no. 1, pp. 1–8, 1995. View at Google Scholar · View at Scopus
  191. S. S. Vandaveer, G. F. Erf, and J. M. Durdik, “Avian T helper one/two immune response balance can be shifted toward inflammation by antigen delivery to scavenger receptors,” Poultry Science, vol. 80, no. 2, pp. 172–181, 2001. View at Google Scholar · View at Scopus
  192. D. Rajagopal, K. A. Ganesh, and P. V. Subba Rao, “Modulation of allergen-specific immune responses to the major shrimp allergen, tropomyosin, by specific targeting to scavenger receptors on macrophages,” International Archives of Allergy and Immunology, vol. 121, no. 4, pp. 308–316, 2000. View at Google Scholar · View at Scopus
  193. M. S. Willis, L. W. Klassen, D. J. Tuma, M. F. Sorrell, and G. M. Thiele, “Adduction of soluble proteins with malondialdehyde-acetaldehyde (MAA) induces antibody production and enhances T-cell proliferation,” Alcoholism, vol. 26, no. 1, pp. 94–106, 2002. View at Google Scholar · View at Scopus
  194. N. Matsushita, H. Komine, A. Grolleau-Julius, S. Pilon-Thomas, and J. J. Mulé, “Targeting MARCO can lead to enhanced dendritic cell motility and anti-melanoma activity,” Cancer Immunology, Immunotherapy, vol. 59, no. 6, pp. 875–884, 2010. View at Publisher · View at Google Scholar · View at Scopus
  195. J. Valladeau, V. Duvert-Frances, J. J. Pin et al., “Immature human dendritic cells express asialoglycoprotein receptor isoforms for efficient receptor-mediated endocytosis,” Journal of Immunology, vol. 167, no. 10, pp. 5767–5774, 2001. View at Google Scholar · View at Scopus
  196. D. Li, G. Romain, A. L. Flamar et al., “Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells,” Journal of Experimental Medicine, vol. 209, no. 1, pp. 109–121, 2012. View at Publisher · View at Google Scholar · View at Scopus
  197. H. H. Lin, M. Stacey, J. Stein-Streilein, and S. Gordon, “F4/80: the macrophage-specific adhesion-GPCR and its role in immunoregulation,” Advances in Experimental Medicine and Biology, vol. 706, pp. 149–156, 2010. View at Publisher · View at Google Scholar · View at Scopus
  198. A. J. Corbett, I. Caminschi, B. S. McKenzie et al., “Antigen delivery via two molecules on the CD8- dendritic cell subset induces humoral immunity in the absence of conventional “danger”,” European Journal of Immunology, vol. 35, no. 10, pp. 2815–2825, 2005. View at Publisher · View at Google Scholar · View at Scopus
  199. D. Eleveld-Trancikova, A. Sanecka, M. A. van Hout-Kuijer et al., “DC-STAMP interacts with ER-resident transcription factor LUMAN which becomes activated during DC maturation,” Molecular Immunology, vol. 47, no. 11-12, pp. 1963–1973, 2010. View at Publisher · View at Google Scholar · View at Scopus
  200. F. C. Hartgers, J. L. Vissers, M. W. Looman et al., “DC-STAMP, a novel multimembrane-spanning molecule preferentially expressed by dendritic cells,” European Journal of Immunology, vol. 30, pp. 3585–3590, 2000. View at Google Scholar
  201. C. Dresch, S. L. Edelmann, P. Marconi, and T. Brocker, “Lentiviral-mediated transcriptional targeting of dendritic cells for induction of T cell tolerance in vivo,” Journal of Immunology, vol. 181, no. 7, pp. 4495–4506, 2008. View at Google Scholar · View at Scopus
  202. R. Dong, D. Moulding, N. Himoudi et al., “Cells with dendritic cell morphology and immunophenotype, binuclear morphology, and immunosuppressive function in dendritic cell cultures,” Cellular Immunology, vol. 272, no. 1, pp. 1–10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  203. V. Moulin, M. E. Morgan, D. Eleveld-Trancikova et al., “Targeting dendritic cells with antigen via dendritic cell-associated promoters,” Cancer Gene Therapy, vol. 19, no. 5, pp. 303–311, 2012. View at Publisher · View at Google Scholar · View at Scopus
  204. F. Nimmerjahn and J. V. Ravetch, “Fcγ receptors: old friends and new family members,” Immunity, vol. 24, no. 1, pp. 19–28, 2006. View at Publisher · View at Google Scholar · View at Scopus
  205. J. M. H. de Jong, D. H. Schuurhuis, A. Ioan-Facsinay et al., “Murine Fc receptors for IgG are redundant in facilitating presentation of immune complex derived antigen to CD8+ T cells in vivo,” Molecular Immunology, vol. 43, no. 13, pp. 2045–2050, 2006. View at Publisher · View at Google Scholar · View at Scopus
  206. K. A. Berlyn, B. Schultes, B. Leveugle, A. A. Noujaim, R. B. Alexander, and D. L. Mann, “Generation of CD4+ and CD8+ T lymphocyte responses by dendritic cells armed with PSA/anti-PSA (antigen/antibody) complexes,” Clinical Immunology, vol. 101, no. 3, pp. 276–283, 2001. View at Publisher · View at Google Scholar · View at Scopus
  207. I. Mende, P. Hoffmann, A. Wolf et al., “Highly efficient antigen targeting to M-DC8+ dendritic cells via FcγRIII/CD16-specific antibody conjugates,” International Immunology, vol. 17, no. 5, pp. 539–547, 2005. View at Publisher · View at Google Scholar · View at Scopus
  208. M. A. Otten and M. van Egmond, “The Fc receptor for IgA (FcαRI, CD89),” Immunology Letters, vol. 92, no. 1-2, pp. 23–31, 2004. View at Publisher · View at Google Scholar · View at Scopus
  209. S. M. M. Hellwig, A. B. van Spriel, J. F. P. Schellekens, F. R. Mooi, and J. G. J. van de Winkel, “Immunoglobulin A-mediated protection against Bordetella pertussis infection,” Infection and Immunity, vol. 69, no. 8, pp. 4846–4850, 2001. View at Publisher · View at Google Scholar · View at Scopus
  210. T. Kobayashi, A. Takauchi, A. B. V. Spriel et al., “Targeting of Porphyromonas gingivalis with a bispecific antibody directed to FcαRI (CD89) improves in vitro clearance by gingival crevicular neutrophils,” Vaccine, vol. 23, no. 5, pp. 585–594, 2004. View at Publisher · View at Google Scholar · View at Scopus
  211. M. E. Rodriguez, S. M. M. Hellwig, D. F. Hozbor, J. Leusen, W. L. van der Pol, and J. G. J. van de Winkel, “Fc receptor-mediated immunity against Bordetella pertussis,” Journal of Immunology, vol. 167, no. 11, pp. 6545–6551, 2001. View at Google Scholar · View at Scopus
  212. M. van Egmond, A. J. H. van Vuuren, H. C. Morion et al., “Human immunoglobulin A receptor (FcαRI, CD89) function in transgenic mice requires both FCR γ chain and CR3 (CD11b/CD18),” Blood, vol. 93, no. 12, pp. 4387–4394, 1999. View at Google Scholar · View at Scopus
  213. A. B. van Spriel, I. E. van den Herik-Oudijk, N. M. van Sorge, H. A. Vilé, J. A. G. van Strijp, and J. G. J. van de Winkel, “Effective phagocytosis and killing of Candida albicans via targeting Fcγ/RI (CD64) or FcαRI (CD89) on neutrophils,” Journal of Infectious Diseases, vol. 179, no. 3, pp. 661–669, 1999. View at Publisher · View at Google Scholar · View at Scopus
  214. M. A. Otten, I. Groenveld, J. G. J. van de Winkel, and M. van Egmond, “Inefficient antigen presentation via the IgA Fc receptor (FcαRI) on dendritic cells,” Immunobiology, vol. 211, no. 6–8, pp. 503–510, 2006. View at Publisher · View at Google Scholar · View at Scopus
  215. B. Pasquier, Y. Lepelletier, C. Baude, O. Hermine, and R. C. Monteiro, “Differential expression and function of IgA receptors (CD89 and CD71) during maturation of dendritic cells,” Journal of Leukocyte Biology, vol. 76, no. 6, pp. 1134–1141, 2004. View at Publisher · View at Google Scholar · View at Scopus
  216. S. N. Karagiannis, J. K. Warrack, K. H. Jennings et al., “Endocytosis and recycling of the complex between CD23 and HLA-DR in human B cells,” Immunology, vol. 103, no. 3, pp. 319–331, 2001. View at Publisher · View at Google Scholar · View at Scopus
  217. A. Getahun, F. Hjelm, and B. Heyman, “IgE enhances antibody and T cell responses in vivo via CD23+ B cells,” Journal of Immunology, vol. 175, no. 3, pp. 1473–1482, 2005. View at Google Scholar · View at Scopus
  218. B. Heyman, L. Tianmin, and S. Gustavsson, “In vivo enhancement of the specific antibody response via the low-affinity receptor for IgE,” European Journal of Immunology, vol. 23, no. 7, pp. 1739–1742, 1993. View at Google Scholar · View at Scopus